Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Gout Flare: early-phase trial registry

4 of 6 indexed Gout Flare trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Gout Flare: 6 US clinical trials tracked, 4 recruiting.

Gout Flare is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition gout-flare

OPEN 4 | RECR 67% | LATE 1 | EARLY 2 | RANK #2866 | SPON 3

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

Gout Flare (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Gout Flare

Gout Flare lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gout Flare on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gout Flare is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gout Flare research.

    Brigham and Women's Hospital accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Gout Flare enrolment sits around 300 participants.

    Median target enrolment is 300 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Gout Flare research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 41

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 4 1

Named interventions

Most-linked intervention names on Gout Flare records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Home hospital care Other
1 trials
Remote Visit Other
1 trials
Placebo Tablet Other
1 trials
Dapansutrile Drug
1 trials
Purified Cortophin Gel 80 U Drug
1 trials
Purified Cortophin Gel, 40 U Drug
1 trials
Home Hospitalization Other
1 trials
ABP-745 Dose B Drug
1 trials

US sites by state

Facility locations filed on Gout Flare trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
Illinois 2 trials
Georgia 2 trials
California 2 trials
Arizona 2 trials
Utah 1 trials
Texas 1 trials
Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gout Flare page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gout Flare condition card totals 6 registered trials; most-linked intervention Home hospital care; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.